These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 9361679)

  • 1. Growth hormone secretion and circulating insulin-like growth factor-I (IGF-I) and IGF binding protein-3 concentrations in children with sickle cell disease.
    Soliman AT; el Banna N; alSalmi I; De Silva V; Craig A; Asfour M
    Metabolism; 1997 Nov; 46(11):1241-5. PubMed ID: 9361679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with beta-thalassaemia.
    Soliman AT; El Banna N; Ansari BM
    Eur J Endocrinol; 1998 Apr; 138(4):394-400. PubMed ID: 9578506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
    Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating growth hormone (GH), insulin-like growth factor-I (IGF-I) and free thyroxine, GH response to clonidine provocation and CT scanning of the hypothalamic-pituitary area in children with sickle cell disease.
    Soliman AT; Darwish A; Mohammed SH; Bassiony MR; el Banna N; Asfour M
    J Trop Pediatr; 1995 Oct; 41(5):285-9. PubMed ID: 8531260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous and provoked growth hormone (GH) secretion and insulin-like growth factor I (IGF-I) concentration in patients with beta thalassaemia and delayed growth.
    Soliman AT; elZalabany MM; Mazloum Y; Bedair SM; Ragab MS; Rogol AD; Ansari BM
    J Trop Pediatr; 1999 Dec; 45(6):327-37. PubMed ID: 10667001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of zinc supplementation on growth hormone secretion, IGF-I, IGFBP-3, somatomedin generation, alkaline phosphatase, osteocalcin and growth in prepubertal children with idiopathic short stature.
    Imamoğlu S; Bereket A; Turan S; Taga Y; Haklar G
    J Pediatr Endocrinol Metab; 2005 Jan; 18(1):69-74. PubMed ID: 15679071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature.
    Blair JC; Camacho-Hübner C; Miraki Moud F; Rosberg S; Burren C; Lim S; Clayton PE; Bjarnason R; Albertsson-Wikland K; Savage MO
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):163-8; discussion 161-2. PubMed ID: 14725676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3.
    Juul A; Skakkebaek NE
    J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empty sella in short children with and without hypothalamic-pituitary abnormalities.
    Soliman AT; Darwish A; Asfour MG
    Indian J Pediatr; 1995; 62(5):597-603. PubMed ID: 10829929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?
    Cianfarani S; Tondinelli T; Spadoni GL; Scirè G; Boemi S; Boscherini B
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):161-7. PubMed ID: 12153594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen priming effect on growth hormone (GH) provocative test: a useful tool for the diagnosis of GH deficiency.
    Martínez AS; Domené HM; Ropelato MG; Jasper HG; Pennisi PA; Escobar ME; Heinrich JJ
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4168-72. PubMed ID: 11095449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
    Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
    J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency.
    Juul A; Holm K; Kastrup KW; Pedersen SA; Michaelsen KF; Scheike T; Rasmussen S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2497-502. PubMed ID: 9253324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin concentration is correlated with IGF-I/IGFBP-3 molar ratio but not with GH secretion in children with short stature.
    Stawerska R; Smyczynska J; Czkwianianc E; Pisarek H; Hilczer M; Lewinski A
    Neuro Endocrinol Lett; 2012; 33(4):412-8. PubMed ID: 22936258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
    Liu HJ; Wang LH; Chen L
    Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor binding protein-3 molar ratio in growth hormone-deficient children.
    Scirè G; Del Bianco C; Spadoni GL; Cianfarani S
    J Endocrinol Invest; 2008 Feb; 31(2):153-8. PubMed ID: 18362507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.